{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:10:11Z","timestamp":1778857811890,"version":"3.51.4"},"reference-count":59,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver disease worldwide. Approximately 20% of individuals with NAFLD develop nonalcoholic steatohepatitis (NASH), which is associated with increased risk of cirrhosis, portal hypertension, and hepatocellular carcinoma. Intestinal microflora, including small intestinal bacterial overgrowth (SIBO), appear to play an important role in the pathogenesis of the disease, as demonstrated in several clinical and experimental studies, by altering intestinal permeability and allowing bacterial endotoxins to enter the circulation. OBJECTIVE: To determine the relationship between SIBO and endotoxin serum levels with clinical, laboratory, and histopathological aspects of NAFLD and the relationship between SIBO and endotoxin serum levels before and after antibiotic therapy. METHODS: Adult patients with a histological diagnosis of NAFLD, without cirrhosis were included. A comprehensive biochemistry panel, lactulose breath test (for diagnosis of SIBO), and serum endotoxin measurement (chromogenic LAL assay) were performed. SIBO was treated with metronidazole 250 mg q8h for 10 days and refractory cases were given ciprofloxacin 500 mg q12h for 10 days. RESULTS: Overall, 42 patients with a histopathological diagnosis of NAFLD were examined. The prevalence of SIBO was 26.2%. Comparison of demographic and biochemical parameters between patients with SIBO and those without SIBO revealed no statistically significant differences, except for use of proton pump inhibitors, which was significantly more frequent in patients with positive breath testing. The presence of SIBO was also associated with greater severity of hepatocellular ballooning on liver biopsy. Although the sample, as a whole, have elevated circulating endotoxin levels, we found no significant differences in this parameter between the groups with and without SIBO. Endotoxin values before and after antibiotic treatment did not differ, even on paired analysis, suggesting absence of any relationship between these factors. Serum endotoxin levels were inversely correlated with HDL levels, and directly correlated with triglyceride levels. CONCLUSION: Serum endotoxin levels did not differ between patients with and without SIBO, nor did these levels change after antibacterial therapy, virtually ruling out the possibility that elevated endotoxinemia in non-cirrhotic patients with NAFLD is associated with SIBO. Presence of SIBO was associated with greater severity of ballooning degeneration on liver biopsy, but not with a significantly higher prevalence of NASH. Additional studies are needed to evaluate the reproducibility and importance of this finding in patients with NAFLD and SIBO.<\/jats:p>","DOI":"10.1590\/s0004-2803.202000000-82","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T06:32:11Z","timestamp":1607754731000},"page":"471-476","source":"Crossref","is-referenced-by-count":7,"title":["PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS"],"prefix":"10.1590","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7839-997X","authenticated-orcid":false,"given":"Vivian Mota","family":"GUIMAR\u00c3ES","sequence":"first","affiliation":[{"name":"Universidade de Taubat\u00e9, Brasil; Unifesp, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6574-5343","authenticated-orcid":false,"given":"Virg\u00ednia Nascimento","family":"SANTOS","sequence":"additional","affiliation":[{"name":"Unifesp, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-1135","authenticated-orcid":false,"given":"Patr\u00edcia Souza de Almeida","family":"BORGES","sequence":"additional","affiliation":[{"name":"Universidade Federal de Goi\u00e1s, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-480X","authenticated-orcid":false,"given":"Jo\u00e3o Luiz Rodrigues","family":"DE FARIAS","sequence":"additional","affiliation":[{"name":"Unifesp, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9182-8238","authenticated-orcid":false,"given":"Penelope","family":"GRILLO","sequence":"additional","affiliation":[{"name":"Unifesp, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-9259","authenticated-orcid":false,"given":"Edison Roberto","family":"PARISE","sequence":"additional","affiliation":[{"name":"Unifesp, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of non-alcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence and outcomes","volume":"64","author":"Younossi ZM","year":"2016","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1073\/pnas.94.6.2557","article-title":"Obesity increases sensitivity to endotoxin liver injury; implications for the pathogeneses of steatohepatitis","volume":"94","author":"Yang SQ","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty disease","volume":"49","author":"Miele L","year":"2009","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1017\/S0007114514002591","article-title":"Non Alcoholic fatty liver disease: need for a balanced nutritional source","volume":"112","author":"Veena J","year":"2014","journal-title":"Br J Nutr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOL.0000000000000259","article-title":"Choline metabolites: gene by diet interactions","volume":"27","author":"Smallwood T","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumor necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg AJ","year":"2001","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Shanab AA","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/jgh.12510","article-title":"Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis","volume":"29","author":"Yuan J","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3748\/wjg.14.313","article-title":"Small intestinal bacteria overgrowth decrease small intestinal motility in the rats","volume":"14","author":"Wu WC","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis Gut Microbiota associated with Inflammation and Impaired Mucosal Immune Function in Intestine of Humans with Non-alcoholic Fatty Liver Disease","volume":"5","author":"Jiang W","year":"2015","journal-title":"Scientific Reports"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease","volume":"7","author":"Harte AL","year":"2010","journal-title":"J Inflamm"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/apt.13327","article-title":"Bacterial endotoxin and non-alcoholic fatty liver disease in general population: a prospective cohort study","volume":"42","author":"Wong VW","year":"2015","journal-title":"Alimentary Pharmacology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostatic model assessment: insulin resistance and beta-cell funtion from fasting glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","journal-title":"Diabetologia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0004-28032010000200009","article-title":"Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals","volume":"47","author":"Salgado ALFA Carvalho L","year":"2010","journal-title":"Arq Gastroenterol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic Steatohepatites Clinical Research Network: design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner DE","year":"2005","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1572-0241.2002.05664.x","article-title":"Using breath test wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation","volume":"97","author":"Romagnuolo J","year":"2002","journal-title":"Am.J.Gastroenterol"},{"key":"ref18","series-title":"Atualiza\u00e7\u00e3o Terapeutica","author":"Prado FC","year":"2005","edition":"22nd ed"},{"key":"ref19","series-title":"Guia de Medicina Ambulatorial e Hospitalar","first-page":"p324","author":"Miszputen SJ","year":"2007","edition":"2nd ed"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed F","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","article-title":"Higth Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Morbid OBesitiy: A contributor to Severe Hepatic Steatosis","volume":"18","author":"Sabat\u00e9 JM","year":"2008","journal-title":"Obes Surg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/hep.23036","article-title":"The gut-liver Axis in nonalcoholic fatty liver disease: Another Pathway to insulin resistance?","volume":"49","author":"Bugianese E","year":"2009","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.26494","article-title":"Microbiota-liver Axis in Hepatic Disease","volume":"59","author":"Chassaing B","year":"2014","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures J","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1478-3231.2008.01723.x","article-title":"Susceptilbility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis","volume":"28","author":"Farhadi A","year":"2008","journal-title":"Liver Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increase intestinal permeability in obese mice: new evidence in the pathogenesis of non-alcoholic steatohepatitis","volume":"292","author":"Brun P","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref27","article-title":"AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review","author":"Quigley EM","year":"2020","journal-title":"Gastroenterology"},{"key":"ref28","article-title":"Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis","author":"Wijarnpreecha K","year":"2019","journal-title":"Digestive Diseases and Sciences"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.15403\/jgld.2014.1121.252.iwg","article-title":"Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease","volume":"25","author":"Fialho A","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1572-0241.2003.07475.x","article-title":"Small Intestinal Motility Disturbances and Bacterial Overgrowth in Patients With Liver Cirrhosis and Portal Hypertension Motility and Portal Hypertension in Cirrhosis","volume":"98","author":"Gunnarsdottir SA","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bpg.2003.10.005","article-title":"Gut microflora in the pathogenesis of the complications of cirrhosis","volume":"18","author":"Garcia-Tsao G","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpg.2006.07.004","article-title":"Prevention and treatment of infections in patients with cirrhosis","volume":"21","author":"Ghassemi S","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref33","first-page":"1686","article-title":"Gastrointestinal dysfunction in liver cirrhosis","volume":"28","author":"Kalaitzakis E","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s10620-005-2720-8","article-title":"Increased orocecal transit time in patients with nonalcoholic fatty liver disease","volume":"50","author":"Soza A","year":"2005","journal-title":"Dig. Dis. Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis","volume":"11","author":"Lo WK","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00535-017-1371-9","article-title":"Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth","volume":"53","author":"Su T","year":"2018","journal-title":"J Gastroenterol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2008.01.026","article-title":"Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis","volume":"48","author":"Lackner C","year":"2008","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2010.04.031","article-title":"Hepatocellular ballooning in NASH","volume":"53","author":"Caldwell S","year":"2010","journal-title":"J Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Non-alcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt EM","year":"2001","journal-title":"Sem Liv Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity","volume":"116","author":"Matteoni CA","year":"1999","journal-title":"Gastroenterol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq N","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.cgh.2013.09.055","article-title":"Breath Testing for Small Intestinal Bacterial Overgrowth: Maximizing Test Accuracy","volume":"12","author":"Saad RJ","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","article-title":"How to interpret hydrogen breath test","volume":"17","author":"Ghoshal UC","year":"2011","journal-title":"J Neurogastroenterol Motil"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1309\/6VJ4DWGYDU0XYJ8Q","article-title":"Correlation of serun TNF-alpha levels and histologic liver injury scores in Nonalcoholic fatty liver disease","volume":"127","author":"Manco M","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui JM","year":"2004","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s11695-007-9243-7","article-title":"Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis","volume":"17","author":"Ruiz AG","year":"2007","journal-title":"Obes Surg"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"44 PM","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling","volume":"4","author":"Imajo K","year":"2012","journal-title":"Cell Metabolism"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/gut.19.10.935","article-title":"Portal and systemic bacteraemia and endotoxaemia in liver disease","volume":"19","author":"Triger DR","year":"1978","journal-title":"Gut"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0016-5085(77)80025-5","article-title":"Endotoxin and bacteraemia in portal blood","volume":"72","author":"Jacob AI","year":"1977","journal-title":"Gastoenterology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","article-title":"Small Intestinal bacterial overgrowth in nonalcoholic setatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8","volume":"56","author":"Shanab AA","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease","volume":"31","author":"Kapil S","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1590-8658(04)00094-5","article-title":"Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver","volume":"36","author":"Loguercio C","year":"2004","journal-title":"Dig. Liver Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0016-5085(78)90867-3","article-title":"Endotoxin(s) and the liver","volume":"75","author":"Munford RS","year":"1978","journal-title":"Gastroenterology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1194\/jlr.M800156-JLR200","article-title":"Chylomicrons promote intestinal absorption of lipopolysaccharides","volume":"50","author":"Ghoshal S","year":"2009","journal-title":"J Lipid Res"},{"key":"ref55","first-page":"1367","article-title":"Effect of Treatment with Paramomycin on Endotoxemia in Patients with Alcoholic Liver Desease. A double Blind, Placebo-Controlled Trial","volume":"21","author":"Bode C","year":"1997","journal-title":"Alcohol Clin Exp Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2337\/dc10-2197","article-title":"Bacterial Endotoxin Activity in Human Serun Is Associated With Dyslipidemia, Insulin Resistance, Obesity and Chronic Inflamation","volume":"35","author":"Lassenius M","year":"2011","journal-title":"Diabetes Care"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.atherosclerosis.2008.06.018","article-title":"Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population","volume":"203","author":"Miller MA","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00134-006-0433-x","article-title":"Lipoproteins in inflammation and sepsis. II Clinical Aspects","volume":"33","author":"Wendel M","year":"2007","journal-title":"Intensive Care Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1189\/jlb.1111537","article-title":"Mechanisms of triglyderide accumulation in activated macrophages","volume":"92","author":"Feingold KR","year":"2012","journal-title":"J Leukoc Biol"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v57n4\/1678-4219-ag-57-04-471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T03:40:24Z","timestamp":1697341224000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032020000400471&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["S0004-28032020000400471"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.202000000-82","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}